AYTU BIOPHARMA, INC
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-22.5M | $-28.2M | $-7.7M | $-5.6M | $-57.3K | $-59.7K | $-136.8K | $-60.3K |
| Depreciation & Amortization | $4.4M | $874.8K | $118.2K | $97.5K | $58.4K | $53.4K | — | — |
| Depreciation | $134.0K | $51.0K | $27.0K | $27.0K | $4.9K | $6.2K | $6.8K | — |
| Amortization | $1.7M | $664.7K | $90.7K | $70.0K | — | — | — | — |
| Stock-Based Compensation | $2.5M | $902.9K | $1.0M | $499.7K | — | — | — | — |
| Net Cash from Operating Activities | $-13.8M | $-10.7M | $-6.6M | $-5.5M | $-37.7K | $-37.8K | $-64.8K | — |
| Investing Activities | ||||||||
| Capital Expenditures | $111.6K | $252.9K | $0 | $9.3K | — | — | — | — |
| Business Acquisitions | — | $0 | $1.0M | — | — | — | — | — |
| Net Cash from Investing Activities | $-3.5M | — | — | — | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $10.2M | — | — | — | $39.5K | $34.0K | $67.3K | — |
| Net Change in Cash | $-7.2M | $701.1K | $4.7M | $-274.1K | — | — | — | — |
| Free Cash Flow | $-13.9M | $-10.9M | $-6.6M | $-5.5M | — | — | — | — |